会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MEDICAMENT COMPOSITE
    • 药物组合物
    • WO1997038727A1
    • 1997-10-23
    • PCT/JP1997001303
    • 1997-04-15
    • ASAHI KASEI KOGYO KABUSHIKI KAISHASUGAWARA, ShuichiKAJIKI, MasahiroKURIYAMA, HiroshiKITAGUCHI, Nobuya
    • ASAHI KASEI KOGYO KABUSHIKI KAISHA
    • A61K47/48
    • A61K47/61A61K47/60
    • A composite of medicaments each having a hydroxyl group and represented by the following general formula: A-B-C, wherein A represents a carrier selected among saccharides each having a carboxyl group, polyethylene glycol, aliphatic carboxylic acids and their derivatives, B represents a spacer having amino and carboxyl groups in its molecule, and C represents a medicament having a hydroxyl group. In this case, the carrier A and the spacer B are bonded to each other through the amide linkage formed between the carboxyl group of the carrier A and the amino group of the spacer B, while the spacer B and the medicament C are bonded to each other through the ester bond formed between the carboxyl group of the spacer B and the hydroxyl group of the medicament C. The composite exhibits a surely controlled release rate of the medicament therefrom to increase the migration of the medicament to a target tissue and/or to enhance the efficacy of the medicament.
    • 具有羟基并由以下通式表示的药物复合物:ABC,其中A表示选自具有羧基的糖类,聚乙二醇,脂肪族羧酸及其衍生物的载体,B表示具有氨基和 羧基分子,C代表具有羟基的药物。 在这种情况下,载体A和间隔物B通过形成在载体A的羧基和间隔物B的氨基之间的酰胺键彼此键合,而隔离物B和药物C结合到每个 另一个通过在间隔物B的羧基与药物C的羟基之间形成的酯键。复合材料表现出药物的可靠控制的释放速率,以增加药物向目标组织的迁移和/或 增强药物的功效。